Anixa Biosciences ANIX Institutional Ownership

Updated Oct 11, 2026

Anixa Biosciences Inc (NASDAQ:ANIX) counted 63 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• These investors held 15.75% of Anixa Biosciences' outstanding shares at the end of Q2 2026, up from 15.26% in Q1 2026.
• Total holdings of Anixa Biosciences shares rose 4.62% from Q1 2026, and the number of holders was unchanged from Q2 2025.
• Of these 63 holders, 27 added to their positions, 7 reduced their stakes and 29 left their positions unchanged.
• Institutional investors held 5.34Mn shares of Anixa Biosciences in total at the end of Q2 2026, up 236.09K from the prior quarter and up 86.05K from a year earlier.
• As of June 30, 2026, Vanguard Capital Management LLC held the largest stake in Anixa Biosciences with 1.33Mn shares, or 3.92% of shares outstanding.
• The largest position increases in ANIX for Q2 2026 were by Marshall Wace, LLP (+155.15K shares), UBS Group AG (+33.79K shares), LPL Financial LLC (+30.56K shares), BlackRock, Inc. (+29.65K shares) and GSA Capital Partners LLP (+18.62K shares).
• On the other side, among holders that kept a position in Anixa Biosciences, the largest reductions in Q2 2026 came from Kestra Advisory Services, LLC (-13K shares), Morgan Stanley (-9.37K shares), Geode Capital Management, LLC (-5.54K shares), Westside Investment Management, Inc. (-4K shares) and Renaissance Technologies LLC (-1.8K shares).
• Business Quant data shows the 10 biggest positions in Anixa Biosciences as of Q2 2026 were held by Vanguard Capital Management LLC (1.33Mn shares), UBS Group AG (585.43K shares), Laird Norton Wetherby Trust Company, LLC (578.73K shares), D.A. Davidson & Co. (539.27K shares), Geode Capital Management, LLC (359.19K shares), Marshall Wace, LLP (328.33K shares), BlackRock, Inc. (199.75K shares), Vanguard Fiduciary Trust Co (192.36K shares), State Street Corp (159.04K shares) and GSA Capital Partners LLP (117.47K shares).